Skip to main content

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of HZNP by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−4,444−100.0%Sold outHolders
Q3 20234,444$514.1K<0.1%−17−0.4%ReducedHolders
Q2 20234,461$458.8K<0.1%+527+13.4%AddedHolders
Q1 20233,934$429.4K<0.1%−1,226−23.8%ReducedHolders
Q4 20225,160$587.2K<0.1%+342+7.1%AddedHolders
Q3 20224,818$298.0K<0.1%−3,319−40.8%ReducedHolders
Q2 20228,137$649.0K<0.1%+1,812+28.6%AddedHolders
Q1 20226,325$665.0K<0.1%−1,381−17.9%ReducedHolders
Q4 20217,706$830.0K<0.1%+699+10.0%AddedHolders
Q3 20217,007$768.0K<0.1%+313+4.7%AddedHolders
Q2 20216,694$627.0K<0.1%+1,700+34.0%AddedHolders
Q1 20214,994$460.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.